Company Filing History:
Years Active: 2019
Title: Maria De Pizzol: Innovator in Pharmaceutical Science
Introduction
Maria De Pizzol is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target specific G-protein coupled receptors. Her work is crucial in addressing various metabolic disorders.
Latest Patents
Maria holds a patent for "Sulfonamides as GPR40- and GPR120-agonists." This invention relates to compounds that act as agonists of GPR120 and/or GPR40. These compounds are particularly useful in treating diseases such as type 2 diabetes, insulin resistance, obesity, and related cardiovascular disorders. The patent highlights the potential of these compounds in managing conditions that affect millions worldwide.
Career Highlights
Maria De Pizzol is associated with Dompé Farmaceutici S.p.a., a leading pharmaceutical company. Her role in the company has allowed her to focus on innovative research and development in the field of drug discovery. With her expertise, she has contributed to advancing therapeutic options for patients suffering from metabolic diseases.
Collaborations
Maria collaborates with talented professionals in her field, including Anna Sirico and Mara Zippoli. These collaborations enhance the research environment and foster innovation within the company.
Conclusion
Maria De Pizzol's work exemplifies the impact of innovation in pharmaceutical science. Her contributions to the development of GPR40 and GPR120 agonists are paving the way for new treatments for metabolic disorders. Her dedication to research continues to inspire advancements in healthcare.